Search the Newsreel

Press Release: Marcus & Millichap, Inc. to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026

Marcus & Millichap, Inc. (NYSE: MMI) is scheduled to release its second-quarter 2026 financial results on Thursday, August 6, 2026, after the close of market. Following the release, the company will host a conference call and webcast at 2:00 p.m. Pacific Time (5:00 p.m. …

Marcus & Millichap Schedules Aug. 6 Webcast on Q2 Results

Marcus & Millichap, Inc. (NYSE: MMI) announced it will report its Q2 2026 financial results on Thursday, August 6, 2026, before market open. The company will host a webcast and conference call at 10:30 a.m. Eastern Time to discuss the results, featuring President and …

Marcus (MCS) Expected to Release Quarterly Earnings on Thursday

Marcus (MCS) Reports Next Week: Wall Street Expects Earnings Growth

Arcus Biosciences, AVEO Supply Deal for Kidney Cancer Trial

Arcus Biosciences has announced a clinical supply agreement with AVEO Oncology to evaluate their investigational small-molecule HIF-2α inhibitor, casdatifan, in combination with AVEO’s tivozanib for patients with advanced clear cell renal cell carcinoma. This collaboration aims to assess casdatifan's effectiveness in patients who have …

Arcus Biosciences Announces Clinical Supply Agreement with AVEO Oncology to Evaluate Casdatifan in Combination with Tivozanib for Advanced Kidney Cancer Patients

This agreement supports a new randomized cohort within the ARC-20 study evaluating investigational casdatifan plus tivozanib versus tivozanib alone in patients who received prior HIF-2α-inhibitor therapy Enrollment is expected to begin in the fourth quarter of 2026 HAYWARD, Calif., July 22, 2026--(BUSINESS WIRE)--Arcus Biosciences, …

Marcus & Millichap Brokers Sale of 58-Unit Multifamily Property in Ingleside Illinois

Marcus & Millichap announced the sale of Lincoln Woods Apartments, a 58-unit multifamily property in Ingleside, Illinois. The property attracted strong investor interest due to its value-add opportunity and potential for long-term growth. The sale was brokered by investment specialists Jake Lenti, Ryan D. …

LifeSci Capital Maintains Arcus Biosciences(RCUS.US) With Buy Rating, Maintains Target Price $46

LifeSci Capital has reiterated its Buy rating for Arcus Biosciences (RCUS.US) and maintained its target price at $46. This reflects a continued positive outlook from the firm regarding the company's stock performance.

What is HC Wainwright's Forecast for RCUS FY2029 Earnings?

Marcus & Millichap brokers USD 16.9 million sale of 41-unit Costa Mesa apartment property

Marcus & Millichap facilitated the sale of a 41-unit multifamily property in Costa Mesa, California, for USD 16.9 million. The property, Sundance West Apartment Homes built in 1962, was valued at USD 412,195 per unit. The buyer plans to implement a value-add repositioning strategy …

Marcus & Millichap Arranges $3M Sale of Seattle Apartments

Marcus & Millichap announced the $3 million sale of The Penrith, a 15-unit apartment property in Seattle's University District. The asset, located near the University of Washington, sold for approximately $443 per square foot, exceeding the Seattle market's year-to-date average. The buyer plans light …

Arcus Biosciences to Host Conference Call to Discuss Second-Quarter 2026 Financial Results and Pipeline Updates

Arcus Biosciences (NYSE: RCUS) announced that its management will host a conference call and webcast on Wednesday, August 5th, 2026, at 1:30 PM PT / 4:30 PM ET. The call will discuss the company's financial results for the quarter ended June 30th, 2026, and …

Marcus & Millichap Brokers Sale of Three-Property Seniors Housing Portfolio in Virginia

Marcus & Millichap recently brokered the sale of a three-property seniors housing portfolio in Virginia, totaling 167 units and 295 licensed beds. The properties are located in Roanoke, Bedford, and Danville. Justin Knapp and Joseph Knapp represented the seller, with assistance from Brian Hosey.

Marcus & Millichap Brokers Sale of 33,744-Square-Foot Multi-Tenant Retail Property in Metro Baton Rouge, Louisiana

Marcus & Millichap has successfully brokered the sale of Commerce Centre, a 33,744-square-foot multi-tenant retail property in Prairieville, Louisiana, located southeast of downtown Baton Rouge. The center, built in 2015 with 15 retail suites, was 72 percent occupied at the time of sale. Cole …

Marcus & Millichap Brokers Sale of Seven-Building Memory Care Campus in San Diego County

Marcus & Millichap has brokered the sale of a seven-building memory care campus in San Diego County. The property, developed in 2002 and licensed for over 85 residents, was sold by a publicly traded REIT to an undisclosed all-cash buyer for approximately $170,000 per …

Marcus & Millichap Brokers $15M Sale of Multifamily Property in Wausau, Wisconsin

Marcus & Millichap has brokered the $15 million sale of The Apartments at Riverlife, a 75-unit multifamily property in Wausau, Wisconsin. Dan Bowar of Marcus & Millichap represented both the seller, Riverlife Wausau LLC, and a Wisconsin-based investor as the buyer. The property, built …

Marcus & Millichap brokers sale of 23,000-square-foot industrial property in West Chicago

Marcus & Millichap has successfully brokered the sale of a 23,000-square-foot single-tenant industrial property in West Chicago, Illinois, for $7 million. The transaction was facilitated by Kellan Gilmartin and involved two Illinois-based investors. The property, occupied by TKO Logistics Inc., is located in DuPage …

Arcus Biosciences to Discuss Cancer and Autoimmune Pipeline Aug. 5

Marcus & Millichap (NYSE:MMI) Stock Passes Above Two Hundred Day Moving Average - Should You Sell?

Marcus & Millichap (NYSE:MMI) shares recently traded above their 200-day moving average, reaching $31.22, despite being down 1.2% on the day. Analyst sentiment remains bearish, with an average "Sell" rating and a $28.00 consensus price target. The company met EPS expectations at -$0.08 and …

Marcus Corp (MCS) Shares Surge 3.2% -- What GF Score of 67 Tells Investors

Marcus Corp (MCS) shares surged 3.2% today, bringing its year-to-date gain to 54.8%. Despite this, GuruFocus assesses the stock as 28.4% overvalued, with a GF Value of $18.52 against its current price of $23.78, and a GF Score of 67/100, indicating above-average fundamental strength …

Why Did This Arcus Biosciences Analyst Bump Price Forecast by 33%?

HC Wainwright has increased its price target for Arcus Biosciences (NASDAQ: RCUS) from $32 to $45, while maintaining a Buy rating. This adjustment reflects the company's aggressive expansion into first-line clear cell renal cell carcinoma (ccRCC) development with its drug casdatifan. The analyst's updated …

Arcus Biosciences Jumps 5.5% After HC Wainwright & Co. Maintains Buy

Arcus Biosciences (RCUS) saw its stock jump 5.5% to $28.88 on Monday after HC Wainwright & Co. raised its price target from $32 to $45 while maintaining a Buy rating. This bullish analyst action, coupled with increased trading volume, signifies renewed investor confidence in …

Marcus & Millichap Brokers Sale of 45-Room Country Inn & Suites Hotel in Detroit Lakes

Marcus & Millichap has successfully brokered the sale of a 45-room Country Inn & Suites hotel in Detroit Lakes, Minnesota. Joseph Ferguson, Jon Ruzicka, Reed Gizinski, and Brock Banken represented the seller, DL Hotel Group LLC, and secured a South Dakota-based buyer. The hotel, …

H.C. Wainwright raises Arcus Biosciences stock price target to $45 By Investing.com

H.C. Wainwright has increased its price target for Arcus Biosciences (NASDAQ:RCUS) to $45 from $32, reiterating a Buy rating based on the company's progress in immuno-oncology, particularly with its drug casdatifan for clear cell renal cell carcinoma. The firm highlighted casdatifan's promising progression-free survival …

Arcus Biosciences (NYSE:RCUS) Stock Price Up 6.6% on Analyst Upgrade

Arcus Biosciences (NYSE:RCUS) Price Target Raised to $45.00

Circus Aktie: Prognose auf 5,2 Millionen gekappt

Marcus & Millichap Brokers $2.9M Sale of Neighborhood Retail Center in Fairburn, Georgia

Marcus & Millichap recently brokered the sale of the Shops at Hampton Oaks, a 20,295-square-foot neighborhood retail center in Fairburn, Georgia, for $2.9 million. The property, built in 2008, was 93 percent occupied at the time of sale. Zach Taylor and Eric Abbot represented …

Marcus & Millichap Brokers $2.9 Million Sale of Neighborhood Center in Metro Atlanta

Marcus & Millichap has brokered the sale of the Shops at Hampton Oaks, a 20,295-square-foot neighborhood center in Fairburn, Georgia, for $2.9 million. The property, built in 2008, was 93 percent occupied at the time of sale and features eight retail suites. Brokers Zach …

Marcus & Millichap’s IPA Capital Markets Bolsters Its Eastern Region Capital Markets Team

BOSTON, July 17, 2026--(BUSINESS WIRE)--IPA Capital Markets, a division of Marcus & Millichap (NYSE:MMI) specializing in capital markets services for major private and institutional clients,has hired Ryan Demadis as a managing director in its Boston office. In his new role, Demadis will report to …

Marcus & Millichap Brokers Seniors Housing Portfolio Sale in Virginia

Marcus & Millichap announced the sale of the Cardinal Senior Living Portfolio, a three-property, 167-unit assisted living and memory care portfolio located in Roanoke, Bedford, and Danville, Virginia. The sale, brokered by Justin Knapp and Joseph Knapp, involved a private owner/operator as the seller …

Marcus & Millichap Arranges $15M Sale of 75-Unit Multifamily Property in Wausau Wisconsin

Marcus & Millichap announced the sale of The Apartments at Riverlife, a 75-unit multifamily property in Wausau, Wisconsin, for $15 million. The sale highlights the strong demand for rentals in Wausau due to a tight for-sale housing market, low vacancy rates, and significant rent …

Marcus & Millichap Brokers $5.8M Sale of Medical Office Property in Davison, Michigan

Marcus & Millichap has brokered the $5.8 million sale of a 50,017-square-foot medical office property in Davison, Michigan. The property, built in 2003, is fully occupied by McLaren Health Management Group and The Cottage of Davison. Jacob Keith and David Weinberg of Marcus & …

Marcus & Millichap Brokers Sale of The Jewell in Denver

Marcus & Millichap's Denver office, specifically brokers Jason Hornik and Greg Parker, facilitated the sale of The Jewell, a 93-unit property located at 4470 E. Jewell Ave. in Denver. The asset, built in 1968 and 55 percent occupied at the time of sale, was …

Marcus Corporation (The) (NYSE:MCS) Given Average Rating of "Buy" by Analysts

Marcus Corporation (NYSE:MCS) has received a consensus "Buy" rating from six analysts, with an average one-year price target of $24.25. The company recently exceeded earnings expectations, posting an EPS of ($0.51) against estimates of ($0.54) and revenue of $154.4 million against $148.78 million expected. …

Marcus Corporation Announces Second Quarter Fiscal 2026 Release Date and Conference Call

Marcus Corporation announced it will report its second-quarter fiscal 2026 results before the market opens on Thursday, July 30, 2026. A conference call will follow at 10:00 a.m. Central/11:00 a.m. Eastern time, accessible via the company's investor relations website or by phone. The company, …